{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:30:25Z","timestamp":1790213425023,"version":"4.1.0"},"reference-count":50,"publisher":"American Society for Microbiology","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"MEC | Instituto de Salud Carlos III","award":["PI20\/01428"],"award-info":[{"award-number":["PI20\/01428"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Standard dosing could fail to achieve adequate systemic concentrations in ICU children or may lead to toxicity in children with acute kidney injury. The population pharmacokinetic analysis was used to simultaneously analyze all available data (plasma, prefilter, postfilter, effluent, and urine concentrations) and provide the pharmacokinetic characteristics of meropenem. The probability of target fT &gt; MIC attainment, avoiding toxic levels, during the entire dosing interval was estimated by simulation of different intermittent and continuous infusions in the studied population. A total of 16 critically ill children treated with meropenem were included, with 7 of them undergoing continuous kidney replacement therapy (CKRT). Only 33% of children without CKRT achieved 90% of the time when the free drug concentration exceeded the minimum inhibitory concentration (%fT &gt; MIC) for an MIC of 2 mg\/L. In dose simulations, only continuous infusions (60\u2013120 mg\/kg in a 24-h infusion) reached the objective in patients &lt;30 kg. In patients undergoing CKRT, the currently used schedule (40 mg\/kg\/12 h from day 2 in a short infusion of 30 min) was clearly insufficient in patients &lt;30 kg. Keeping the dose to 40 mg\/kg q8h without applying renal adjustment and extended infusions (40 mg\/kg in 3- or 4-h infusion every 12 h) was sufficient to reach 90% fT &gt; MIC (&gt;2 mg\/L) in patients &gt;10 kg. In patients &lt;10 kg, only continuous infusions reached the objective. In patients &gt;30 kg, 60 mg\/kg in a 24-h infusion is sufficient and avoids toxicity. This population model could help with an individualized dosing approach that needs to be adopted in critically ill pediatric patients. Critically ill patients subjected to or not to CKRT may benefit from the administration of meropenem in an extended or continuous infusion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/aac.01729-23","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T13:01:11Z","timestamp":1713963671000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children"],"prefix":"10.1128","author":[{"given":"Laura","family":"Butrague\u00f1o-Laiseca","sequence":"first","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IISGM), Madrid, Spain"},{"name":"Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain"},{"name":"Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21\/0012\/0011, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki F.","family":"Troconiz","sequence":"additional","affiliation":[{"name":"Pharmacometrics and Systems Pharmacology Research Unit, Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Grau","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital del Mar, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Campillo","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital del Mar, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Padilla","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Nicole","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IISGM), Madrid, Spain"},{"name":"Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain"},{"name":"Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21\/0012\/0011, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sl\u00f6cker","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IISGM), Madrid, Spain"},{"name":"Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain"},{"name":"Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21\/0012\/0011, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herrera","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IISGM), Madrid, Spain"},{"name":"Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain"},{"name":"Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21\/0012\/0011, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-1179","authenticated-orcid":true,"given":"Mar\u00eda Jos\u00e9","family":"Santiago","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IISGM), Madrid, Spain"},{"name":"Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain"},{"name":"Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21\/0012\/0011, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13369"},{"key":"e_1_3_4_3_2","unstructured":"European Medicines Agency. 2021. Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products. Available from: www.ema.europa.eu\/en\/use-pharmacokinetics-pharmacodynamics-development-antibacterial-madicinal-products"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06050-1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu027"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01179-2"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13344"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01909-20"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.04.025"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-22.4.276"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0298-7"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00583-19"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058823"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.5301\/ijao.5000587"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02183-19"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02832-w"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011970125687"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.58.2.259"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/children9121995"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-016-9487-8"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3194-x"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky314"},{"key":"e_1_3_4_27_2","first-page":"497","article-title":"Elevated \u03b2-lactam concentrations associated with neurological deterioration in ICU septic patients","volume":"81","author":"Beumier M","year":"2015","unstructured":"Beumier M, Casu GS, Hites M, Wolff F, Cotton F, Vincent JL, Jacobs F, Taccone FS. 2015. Elevated \u03b2-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol 81:497\u2013506.","journal-title":"Minerva Anestesiol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071505"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx209"},{"key":"e_1_3_4_30_2","unstructured":"R Core Team. 2019. R: a language and environment for statistical computing"},{"key":"e_1_3_4_31_2","unstructured":"RStudio Team. 2020. RStudio: integrated development environment for R"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2003.11.003"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.712276"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201667"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00822-22"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1079680"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01312-22"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020383"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/590064"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02761-7"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.03.031"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00760-20"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00712-15"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0622-8"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.04.052"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030421"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-021-00709-w"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081585"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/1178636118804549"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00713-4"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106856"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2844"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-27.7.677"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01729-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01729-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T13:01:27Z","timestamp":1713963687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01729-23"}},"subtitle":[],"editor":[{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":50,"alternative-id":["10.1128\/aac.01729-23"],"URL":"https:\/\/doi.org\/10.1128\/aac.01729-23","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"2024-01-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01729-23"}}